274 related articles for article (PubMed ID: 31151143)
1. Impact and Relevance of the Unfolded Protein Response in HNSCC.
Pluquet O; Galmiche A
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151143
[TBL] [Abstract][Full Text] [Related]
2. Targeting the unfolded protein response in head and neck and oral cavity cancers.
Cole DW; Svider PF; Shenouda KG; Lee PB; Yoo NG; McLeod TM; Mutchnick SA; Yoo GH; Kaufman RJ; Callaghan MU; Fribley AM
Exp Cell Res; 2019 Sep; 382(1):111386. PubMed ID: 31075256
[TBL] [Abstract][Full Text] [Related]
3. Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma.
Rahman S; Kraljević Pavelić S; Markova-Car E
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151182
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapeutic Approaches to Head and Neck Cancer.
Nasser H; St John M
Crit Rev Oncog; 2018; 23(3-4):161-171. PubMed ID: 30311572
[TBL] [Abstract][Full Text] [Related]
5. The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial.
Weed DT; Zilio S; Reis IM; Sargi Z; Abouyared M; Gomez-Fernandez CR; Civantos FJ; Rodriguez CP; Serafini P
Front Immunol; 2019; 10():1206. PubMed ID: 31214178
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic regulation of the PERK/ATF4/LAMP3-arm of the unfolded protein response in head and neck squamous cell carcinoma.
Nagelkerke A; Sweep FC; Stegeman H; Grénman R; Kaanders JH; Bussink J; Span PN
Head Neck; 2015 Jun; 37(6):896-905. PubMed ID: 24634103
[TBL] [Abstract][Full Text] [Related]
7. Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma.
Horn D; Hess J; Freier K; Hoffmann J; Freudlsperger C
Expert Opin Ther Targets; 2015 Jun; 19(6):795-805. PubMed ID: 25652792
[TBL] [Abstract][Full Text] [Related]
8. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
9. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
Solomon B; Young RJ; Rischin D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
[TBL] [Abstract][Full Text] [Related]
10. Targeting the PI3K Pathway in Head and Neck Squamous Cell Carcinoma.
Isaacsson Velho PH; Castro G; Chung CH
Am Soc Clin Oncol Educ Book; 2015; ():123-8. PubMed ID: 25993150
[TBL] [Abstract][Full Text] [Related]
11. Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.
Zhang L; Li Z; Liu Y; Xu S; Tandon M; Appelboom B; LaValle CR; Chiosea SI; Wang L; Sen M; Lui VWY; Grandis JR; Wang QJ
BMC Cancer; 2018 Nov; 18(1):1107. PubMed ID: 30419840
[TBL] [Abstract][Full Text] [Related]
12. Clinical correlation of opposing molecular signatures in head and neck squamous cell carcinoma.
Qadir F; Lalli A; Dar HH; Hwang S; Aldehlawi H; Ma H; Dai H; Waseem A; Teh MT
BMC Cancer; 2019 Aug; 19(1):830. PubMed ID: 31443700
[TBL] [Abstract][Full Text] [Related]
13. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
[TBL] [Abstract][Full Text] [Related]
14. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206.
Xue K; Li J; Nan S; Zhao X; Xu C
Life Sci; 2019 Aug; 231():116459. PubMed ID: 31075234
[TBL] [Abstract][Full Text] [Related]
16. AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2.
Deng P; Wang J; Zhang X; Wu X; Ji N; Li J; Zhou M; Jiang L; Zeng X; Chen Q
Carcinogenesis; 2018 Jul; 39(7):937-947. PubMed ID: 29741610
[TBL] [Abstract][Full Text] [Related]
17. PRRX1 Regulates Cellular Phenotype Plasticity and Dormancy of Head and Neck Squamous Cell Carcinoma Through miR-642b-3p.
Jiang J; Zheng M; Zhang M; Yang X; Li L; Wang SS; Wu JS; Yu XH; Wu JB; Pang X; Tang YJ; Tang YL; Liang XH
Neoplasia; 2019 Feb; 21(2):216-229. PubMed ID: 30622052
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.
Summerer I; Hess J; Pitea A; Unger K; Hieber L; Selmansberger M; Lauber K; Zitzelsberger H
BMC Genomics; 2015 Sep; 16(1):654. PubMed ID: 26328888
[TBL] [Abstract][Full Text] [Related]
20. Integration of molecular targeted therapy with radiation in head and neck cancer.
Du Y; Peyser ND; Grandis JR
Pharmacol Ther; 2014 Apr; 142(1):88-98. PubMed ID: 24280066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
